Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 62,954 | 41,337 | 47,603 | 40,956 | 48,875 |
| Gross Profit | 62,954 | 41,337 | 47,603 | 40,956 | 48,875 |
| Operating Expenses | 83,226 | 81,581 | 76,710 | 72,605 | 71,775 |
| Operating Income | -20,272 | -40,244 | -29,107 | -31,649 | -22,900 |
| Interest Expense | 4 | 4 | 4 | 5 | 5 |
| Other Income | 4,014 | -21 | -854 | -4,932 | 1,056 |
| Pre-tax Income | -16,262 | -40,269 | -29,965 | -36,586 | -21,849 |
| Income Tax | 810 | 546 | N/A | N/A | 0 |
| Net Income Continuous | -17,072 | -40,815 | -29,965 | -36,586 | -21,849 |
| Net Income | $-17,072 | $-40,815 | $-29,965 | $-36,586 | $-21,849 |
| EPS Basic Total Ops | -0.22 | -0.53 | -0.39 | -0.49 | -0.29 |
| EPS Basic Continuous Ops | -0.22 | -0.53 | -0.39 | -0.49 | -0.29 |
| EPS Diluted Total Ops | -0.22 | -0.53 | -0.39 | -0.49 | -0.29 |
| EPS Diluted Continuous Ops | -0.22 | -0.53 | -0.39 | -0.49 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.53 | -0.39 | -0.49 | -0.29 |
| EBITDA(a) | $-17,202 | $-37,396 | $-27,503 | $-30,508 | $-22,215 |